Rosh Maternal Fetal Medicine is categorized under Clinics in New York City, NY and active since 2005.
Rosh Maternal Fetal Medicine was established in 2005, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Clinics business, which does work in the B2C market, and is classified as a Clinics, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Daniel Roshan, Owner at the company’s single location by writing to 213 Madison Avenue, New York City, New York NY 10016 or by phoning (212) 725-0123. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Rosh Maternal Fetal Medicine |
| Contact Person: | Daniel Roshan, Owner |
| Address: | 213 Madison Avenue, New York City, New York 10016 |
| Phone Number: | (212) 725-0123 |
| Website Address: | roshmfm.com |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 2005 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Clinics |
| SIC Code: | 8011 |
| NAICS Code: | 6214930 |
| Share This Business: |
Rosh Maternal Fetal Medicine was started in 2005 to provide professional Clinics under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Daniel Roshan, Owner for inquiries that concern Rosh Maternal Fetal Medicine by calling the company number (212) 725-0123, as your correspondence is most welcome. Additionally, the physical location of the single location of Rosh Maternal Fetal Medicine can be found at the coordinates 40.74898,-73.982237 as well as the street address 213 Madison Avenue in New York City, New York 10016.
For its online presence, you may visit Rosh Maternal Fetal Medicine’s website at roshmfm.com and engage with its social media outlets through on Twitter and on Facebook.